← Open Payments lookup

STACEY DALE: Open Payments

NPI 1336848324 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,564 in 77 payments from 12 companies in 2025. Trend: 2023 $132 · 2024 $926 · 2025 $1,564

Food & beverage: $1,552Education: $12
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.21$442
Vanda Pharmaceuticals Inc.11$231
ABBVIE INC.15$207
Otsuka America Pharmaceutical, Inc.9$179
E.R. Squibb & Sons, L.L.C.3$154
Lundbeck LLC4$84
Axsome Therapeutics, Inc.4$75
Supernus Pharmaceuticals, Inc.3$55
Teva Pharmaceuticals USA, Inc.3$47
Janssen Pharmaceuticals, Inc2$46

Products named: INGREZZA, VRAYLAR, REXULTI, COBENFY, HETLIOZ, FANAPT, Auvelity, ABILIFY ASIMTUFII.

Industry payments across MD — which companies pay providers there.